Biotech / Medical : Why was Chad Therapeutics Inventory growth 117% -- Ignore unavailable to you. Want to Upgrade?



To: Buzz Mills who wrote (277)12/3/1997 12:58:00 AM
From: Franklin M. HumphreysRespond to of 303
 
>>>>FH--suggest you put your browser on ignore.<<<<

No need for that, since all posts are there for everyone to see who can navigate the system, I seriously thought you were experiencing a problem.
Frank



To: Buzz Mills who wrote (277)12/3/1997 8:00:00 PM
From: Buzz MillsRead Replies (2) | Respond to of 303
 
CTU closed @ 9 5/16, -1/16, Bid 9 1/16 x Ask 9 7/16 ...Vol..5.1K

This stock will do well but it may take awhile. Today's trading range was 9 1/4 to 9 3/8--very low volume. The fact that CTU has FDA approval for the Total O2 system, and their competition doesn't have FDA approval for their system, and that the Medicare cuts in reimbursements for oxygen services are effective in January, will begin to have a positive influence on the stock.

The following information is posted for the benefit of any newcomers to the thread.

Chad Therapeutics Receives FDA Approval
techstocks.com 

Chad's earnings release 11/13/97
techstocks.com 
techstocks.com 

Chad's Oct. 07 Total O2 Press Release:
techstocks.com 

From the "Chad Today" newspaper--articles on the Total O2
techstocks.com 
techstocks.com 
techstocks.com 
techstocks.com 
techstocks.com 


Copyright © 1995-2013 Knight Sac Media. All rights reserved.